ArticleCancer research2009

Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.

Alexandra C Racanelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.